Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderly.

Abstract : Numerous large randomized controlled trials have assessed the benefit of prophylactic anticoagulation for venous thromboembolism in selected patients. However, few trials were conducted in elderly patients, as this issue was not addressed in this specific population,or as elderly patients were excluded of these studies. Therefore, as the risk of a first episode of venous thromboembolism (in surgical and in medical setting) and the risk of a major anticoagulant-related bleeding are both increased in elderly subjects, the results of the main available studies can not be extrapolated to this population. Consequently, in practice, the balance between expected benefit and risk of prophylactic anticoagulation should be carefully assessed for each individual elderly patient taking in account the specific risk of venous thromboembolism in elderly in the absence of anticoagulation, the risk of anticoagulant related bleeding according to the type of anticoagulant treatment and the intrinsic risk of bleeding of elderly subjects and, lastly, the available guideline recommendations. In order to improve such evaluation, it is anticipated that further prophylactic studies are needed in elderly patients. In addition, the development of anticoagulation clinics and new oral anticoagulants should help to reduce anticoagulant related bleeding for an equivalent, or an increased, benefit.
Type de document :
Article dans une revue
Pathophysiology of Haemostasis and Thrombosis, Karger, 2003, 33 (5-6), pp.362-5. 〈10.1159/000083830〉
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-00722270
Contributeur : Ghislaine Calvez <>
Soumis le : mercredi 1 août 2012 - 10:24:59
Dernière modification le : mercredi 10 janvier 2018 - 14:42:02

Identifiants

Collections

Citation

Francis Couturaud, Karine Lacut, Christophe Leroyer, Dominique Mottier. Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderly.. Pathophysiology of Haemostasis and Thrombosis, Karger, 2003, 33 (5-6), pp.362-5. 〈10.1159/000083830〉. 〈hal-00722270〉

Partager

Métriques

Consultations de la notice

42